Back

Lipid plaque density index as a phenotypic plaque feature which benefits from achieving LDL-C <55 mg/dL: Observations from the REASSURE-NIRS Multi-center Registry.

29 August 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention (1) Secondary Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hirokazu Nishido

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)

6 More presentations in this session

Presentation thumbnail
Cholesterol and risk of ST-segment elevation versus non-ST-segment elevation myocardial infarction: a population-based cohort study
Professor M. Maeng (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Which feature of the metabolic syndrome is better predictor for coronary artery disease morbidity and mortality; a prospective 10-year analysis
Associate Professor L. Bikdelu (Mashhad, IR)
Abstract Slides Video
Presentation thumbnail
Low dose colchicine for secondary prevention in patients with previous atherosclerotic event: a systematic review and meta-analysis of randomised trials
Doctor R. Barbosa Sousa (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
5-year risk of progression to type 2 diabetes in patients with myocardial infarction and overweight or obesity: a cohort study of the preventive potential of semaglutide treatment
Doctor P. Tonnesen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Enhancing the precision of lipid management quality assessment in ASCVD using large language models
Doctor D. Nguyen (Dallas, US)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Inclisiran-containing low-density lipoprotein cholesterol reduction effectively stabilizes atherosclerotic plaques
thumbnail
Congress Presentation
Association between high-intensity lipid-lowering therapy and atherosclerotic plaque content changes assed by iMAP-IVUS and near-infrared spectroscopy in patients with premature atherosclerosis
thumbnail
Congress Presentation
Intensified hypolipidaemic therapy with inclisiran for atherosclerotic plaque stabilization

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources